Research ArticleArticle
Effects on Gene Expression in Rat Liver after Administration of RXR Agonists: UAB30, 4-Methyl-UAB30, and Targretin (Bexarotene)
Peter T. Vedell, Yan Lu, Clinton J. Grubbs, Yuxin Yin, Hui Jiang, Kirby I. Bland, Donald D. Muccio, Dusica Cvetkovic, Ming You and Ronald Lubet
Molecular Pharmacology March 2013, 83 (3) 698-708; DOI: https://doi.org/10.1124/mol.112.082404
Peter T. Vedell
Medical College of Wisconsin, Cancer Center, Department of Pharmacology Toxicology, Milwaukee, Wisconsin (P.T.V., Y.L., Y.Y., H.J., K.I.B., M.Y.); University of Alabama at Birmingham, Departments of Surgery and Chemistry, Birmingham, Alabama (C.J.G., K.I.B., D.D.M.); Fox Chase Cancer Center, Philadelphia, Pennsylvania (D.C.); and National Cancer Institute, Executive Plaza North, Bethesda, Maryland (R. L.)
Yan Lu
Medical College of Wisconsin, Cancer Center, Department of Pharmacology Toxicology, Milwaukee, Wisconsin (P.T.V., Y.L., Y.Y., H.J., K.I.B., M.Y.); University of Alabama at Birmingham, Departments of Surgery and Chemistry, Birmingham, Alabama (C.J.G., K.I.B., D.D.M.); Fox Chase Cancer Center, Philadelphia, Pennsylvania (D.C.); and National Cancer Institute, Executive Plaza North, Bethesda, Maryland (R. L.)
Clinton J. Grubbs
Medical College of Wisconsin, Cancer Center, Department of Pharmacology Toxicology, Milwaukee, Wisconsin (P.T.V., Y.L., Y.Y., H.J., K.I.B., M.Y.); University of Alabama at Birmingham, Departments of Surgery and Chemistry, Birmingham, Alabama (C.J.G., K.I.B., D.D.M.); Fox Chase Cancer Center, Philadelphia, Pennsylvania (D.C.); and National Cancer Institute, Executive Plaza North, Bethesda, Maryland (R. L.)
Yuxin Yin
Medical College of Wisconsin, Cancer Center, Department of Pharmacology Toxicology, Milwaukee, Wisconsin (P.T.V., Y.L., Y.Y., H.J., K.I.B., M.Y.); University of Alabama at Birmingham, Departments of Surgery and Chemistry, Birmingham, Alabama (C.J.G., K.I.B., D.D.M.); Fox Chase Cancer Center, Philadelphia, Pennsylvania (D.C.); and National Cancer Institute, Executive Plaza North, Bethesda, Maryland (R. L.)
Hui Jiang
Medical College of Wisconsin, Cancer Center, Department of Pharmacology Toxicology, Milwaukee, Wisconsin (P.T.V., Y.L., Y.Y., H.J., K.I.B., M.Y.); University of Alabama at Birmingham, Departments of Surgery and Chemistry, Birmingham, Alabama (C.J.G., K.I.B., D.D.M.); Fox Chase Cancer Center, Philadelphia, Pennsylvania (D.C.); and National Cancer Institute, Executive Plaza North, Bethesda, Maryland (R. L.)
Kirby I. Bland
Medical College of Wisconsin, Cancer Center, Department of Pharmacology Toxicology, Milwaukee, Wisconsin (P.T.V., Y.L., Y.Y., H.J., K.I.B., M.Y.); University of Alabama at Birmingham, Departments of Surgery and Chemistry, Birmingham, Alabama (C.J.G., K.I.B., D.D.M.); Fox Chase Cancer Center, Philadelphia, Pennsylvania (D.C.); and National Cancer Institute, Executive Plaza North, Bethesda, Maryland (R. L.)
Donald D. Muccio
Medical College of Wisconsin, Cancer Center, Department of Pharmacology Toxicology, Milwaukee, Wisconsin (P.T.V., Y.L., Y.Y., H.J., K.I.B., M.Y.); University of Alabama at Birmingham, Departments of Surgery and Chemistry, Birmingham, Alabama (C.J.G., K.I.B., D.D.M.); Fox Chase Cancer Center, Philadelphia, Pennsylvania (D.C.); and National Cancer Institute, Executive Plaza North, Bethesda, Maryland (R. L.)
Dusica Cvetkovic
Medical College of Wisconsin, Cancer Center, Department of Pharmacology Toxicology, Milwaukee, Wisconsin (P.T.V., Y.L., Y.Y., H.J., K.I.B., M.Y.); University of Alabama at Birmingham, Departments of Surgery and Chemistry, Birmingham, Alabama (C.J.G., K.I.B., D.D.M.); Fox Chase Cancer Center, Philadelphia, Pennsylvania (D.C.); and National Cancer Institute, Executive Plaza North, Bethesda, Maryland (R. L.)
Ming You
Medical College of Wisconsin, Cancer Center, Department of Pharmacology Toxicology, Milwaukee, Wisconsin (P.T.V., Y.L., Y.Y., H.J., K.I.B., M.Y.); University of Alabama at Birmingham, Departments of Surgery and Chemistry, Birmingham, Alabama (C.J.G., K.I.B., D.D.M.); Fox Chase Cancer Center, Philadelphia, Pennsylvania (D.C.); and National Cancer Institute, Executive Plaza North, Bethesda, Maryland (R. L.)
Ronald Lubet
Medical College of Wisconsin, Cancer Center, Department of Pharmacology Toxicology, Milwaukee, Wisconsin (P.T.V., Y.L., Y.Y., H.J., K.I.B., M.Y.); University of Alabama at Birmingham, Departments of Surgery and Chemistry, Birmingham, Alabama (C.J.G., K.I.B., D.D.M.); Fox Chase Cancer Center, Philadelphia, Pennsylvania (D.C.); and National Cancer Institute, Executive Plaza North, Bethesda, Maryland (R. L.)
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Effects of RXR Agonists on Gene Expression
Peter T. Vedell, Yan Lu, Clinton J. Grubbs, Yuxin Yin, Hui Jiang, Kirby I. Bland, Donald D. Muccio, Dusica Cvetkovic, Ming You and Ronald Lubet
Molecular Pharmacology March 1, 2013, 83 (3) 698-708; DOI: https://doi.org/10.1124/mol.112.082404
Research ArticleArticle
Effects of RXR Agonists on Gene Expression
Peter T. Vedell, Yan Lu, Clinton J. Grubbs, Yuxin Yin, Hui Jiang, Kirby I. Bland, Donald D. Muccio, Dusica Cvetkovic, Ming You and Ronald Lubet
Molecular Pharmacology March 1, 2013, 83 (3) 698-708; DOI: https://doi.org/10.1124/mol.112.082404
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement